Elite Pharmaceuticals ELTP
OTC ELTP
$0.37 +0.05 (+14.06%)
As of: Nov 16, 2026 · 12:26 PM EST

Elite Pharmaceuticals (ELTP) Net Long-Term Debt Issued (Repaid) (2009 - 2026)

Updated

Elite Pharmaceuticals' Non-Current Debt came in at $2.11 million for fiscal Q2 2027 (quarter ended Sep 30, 2026), down 4.3% from $2.2 million a year earlier and down 1.1% from the prior quarter.

Analysis

Elite Pharmaceuticals (ELTP) Net Long-Term Debt Issued (Repaid) (2009 - 2026) Analysis & Trends

At the end of FY2026 (ended Mar 31, 2026), Elite Pharmaceuticals' Non-Current Debt was $2.15 million, down 4.1% from FY2025.

  • Non-Current Debt has declined in each of the last three fiscal years, though with a five-year compound annual growth rate of 11.7% (FY2021 to FY2026).
  • Going back by fiscal year, Non-Current Debt was $2.25 million in FY2025 (-5.1%), $2.37 million in FY2024 (-6.6%), $2.53 million in FY2023 (+122.2%) and $1.14 million in FY2022 (-8.1%).
  • The fiscal Q2 2027 figure represents the lowest quarterly Non-Current Debt since fiscal Q4 2022.
  • Year-over-year, Non-Current Debt has declined for 14 consecutive quarters, with an average decline of 4.5% over the last eight quarters.
  • The fastest year-over-year change in Non-Current Debt over five years came in fiscal Q1 2023 (growth of 896.4%), and the weakest in fiscal Q3 2024 (a decline of 83.8%).
  • Business Quant data shows ELTP's Non-Current Debt at $2.13 million (Q1 2027), $2.15 million (Q4 2026) and $2.18 million (Q3 2026) in the three fiscal quarters before Q2 2027.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net LT Debt (Qtr)
1 Eli Lilly 1,291.18 Bn 1,264.79 Bn 20.46 Bn -
2 Johnson & Johnson 686.56 Bn 606.42 Bn 17.30 Bn -1.00 Mn
3 AbbVie 525.29 Bn 493.30 Bn 13.12 Bn 9.98 Bn
4 Merck 362.24 Bn 325.18 Bn 13.19 Bn -
5 Novartis Ag 313.66 Bn 286.90 Bn - -
6 Astrazeneca 286.68 Bn 260.20 Bn 13.26 Bn 4.91 Bn
7 Amgen 253.44 Bn 205.10 Bn 7.58 Bn -3.05 Bn
8 Gilead Sciences 210.62 Bn 185.73 Bn 6.73 Bn -19.00 Mn
9 Pfizer 165.41 Bn 112.77 Bn 12.56 Bn -
10 Elite Pharmaceuticals 397.46 Mn 270.87 Mn 15.99 Mn -243,524.00
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 -243,524.00
Jun 30, 2026 -96,072.00
Mar 31, 2026 -97,187.00
Dec 31, 2025 -96,594.00
Sep 30, 2025 -234,360.00
Jun 30, 2025 -8.09 Mn
Mar 31, 2025 -90,047.00
Dec 31, 2024 -87,963.00
Sep 30, 2024 -216,850.00
Jun 30, 2024 -71,329.00
Mar 31, 2024 -350,171.00
Jun 30, 2023 4.00 Mn
Mar 31, 2023 -12.35 Mn
Dec 31, 2022 1.00
Sep 30, 2022 2.55 Mn
Jun 30, 2022 12.00 Mn
Mar 31, 2022 -94,244.00
Dec 31, 2021 -462,889.00
Mar 31, 2021 -1.20 Mn
Jun 30, 2020 1.01 Mn
API Access

Elite Pharmaceuticals Net Long-Term Debt Issued (Repaid) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-debt&ticker=ELTP&period=max&api_key=YOUR_API_KEY